Leronlimab stops inflammation in a broad spectrum of disease. Someone doesn’t want that to happen. We better hope Leronlimab makes it to market, or in just a few short years millions are going to pay the price. I am an investigator by nature and in craft in the past. I always ask WHY. Why is there a monumental effort against this drug receiving even the slightest regulatory chance of approval? What possible harm could it do during a pandemic that is causing so many horrific deaths? Who gains and why from stoping it?
News 
Market Data 
Discover 
